351 related articles for article (PubMed ID: 10189324)
1. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial.
von Schacky C; Angerer P; Kothny W; Theisen K; Mudra H
Ann Intern Med; 1999 Apr; 130(7):554-62. PubMed ID: 10189324
[TBL] [Abstract][Full Text] [Related]
2. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group.
Sacks FM; Stone PH; Gibson CM; Silverman DI; Rosner B; Pasternak RC
J Am Coll Cardiol; 1995 Jun; 25(7):1492-8. PubMed ID: 7759696
[TBL] [Abstract][Full Text] [Related]
3. Fish oil reduced heart disease in controlled trial.
AIDS Treat News; 1999 Apr; (No 317):3-4. PubMed ID: 11366995
[TBL] [Abstract][Full Text] [Related]
4. Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries.
Angerer P; Kothny W; Störk S; von Schacky C
Cardiovasc Res; 2002 Apr; 54(1):183-90. PubMed ID: 12062374
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Agh F; Mohammadzadeh Honarvar N; Djalali M; Nematipour E; Gholamhoseini S; Zarei M; Ansari S; Javanbakht MH
Arch Iran Med; 2017 Jan; 20(1):28-33. PubMed ID: 28112528
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
7. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
9. The effect of n-3 fatty acids on coronary atherosclerosis: results from SCIMO, an angiographic study, background and implications.
von Schacky C; Baumann K; Angerer P
Lipids; 2001; 36 Suppl():S99-102. PubMed ID: 11838000
[TBL] [Abstract][Full Text] [Related]
10. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease.
Erkkilä AT; Lichtenstein AH; Mozaffarian D; Herrington DM
Am J Clin Nutr; 2004 Sep; 80(3):626-32. PubMed ID: 15321802
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty.
Bairati I; Roy L; Meyer F
Circulation; 1992 Mar; 85(3):950-6. PubMed ID: 1537131
[TBL] [Abstract][Full Text] [Related]
12. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
Barbosa MM; Melo AL; Damasceno NR
Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
[TBL] [Abstract][Full Text] [Related]
13. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
14. Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial.
Chen JS; Hill CL; Lester S; Ruediger CD; Battersby R; Jones G; Cleland LG; March LM
Osteoporos Int; 2016 May; 27(5):1897-905. PubMed ID: 26694596
[TBL] [Abstract][Full Text] [Related]
15. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial.
Stark KD; Park EJ; Maines VA; Holub BJ
Am J Clin Nutr; 2000 Aug; 72(2):389-94. PubMed ID: 10919932
[TBL] [Abstract][Full Text] [Related]
16. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960
[TBL] [Abstract][Full Text] [Related]
17. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
Kar S
Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
[TBL] [Abstract][Full Text] [Related]
18. Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: a randomized, controlled trial.
Poppitt SD; Howe CA; Lithander FE; Silvers KM; Lin RB; Croft J; Ratnasabapathy Y; Gibson RA; Anderson CS
Stroke; 2009 Nov; 40(11):3485-92. PubMed ID: 19745175
[TBL] [Abstract][Full Text] [Related]
19. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
20. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
Geleijnse JM; Giltay EJ; Kromhout D
Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
